Ticker
NRIXCompany Name
NURIX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Debt | Shareholders Equity | Invested Capital |
---|---|---|---|
9/30/2025 | $ 56.49M | $ 372.25M | $ 428.74M |
6/30/2025 | $ 51.93M | $ 447.6M | $ 499.53M |
3/31/2025 | $ 26.62M | $ 480.92M | $ 507.54M |
12/31/2024 | $ 28.3M | $ 526.99M | $ 555.3M |
9/30/2024 | $ 27.14M | $ 376.86M | $ 404M |
6/30/2024 | $ 28.82M | $ 370.69M | $ 399.51M |
3/31/2024 | $ 29.16M | $ 168.75M | $ 197.9M |
12/31/2023 | $ 30.61M | $ 200.49M | $ 231.11M |
9/30/2023 | $ 8M | $ 233.82M | $ 241.82M |
6/30/2023 | $ 9.34M | $ 259.92M | $ 269.26M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt + Equity
(=) Inv. Capital
Inv. Capital for NURIX THERAPEUTICS INC is calculated as follows: Debt [ $ 0 ] + Equity [ $ 290.27M ]
(=) Inv. Capital [ $ 290.27M ]
Minimum
Mar 31, 2024
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 3.44K |
---|---|
min | $ -1.51B |
max | $ 4.11B |
average | $ 758.9M |
median | $ 302.53M |
std | $ 1B |